Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology, cardiovascular, and hormonal syndromes. The company also manufactures and distributes health supplements, including Clotamin, a specialized over-the-counter multivitamin dietary supplement for patients on Warfarin. In addition, it sells traditional pharmaceuticals to its distribution customers, such as antibiotics, vaccines, and other oral and injectable pharmaceuticals; and specializes in the formulation of drugs. The company was formerly known as Sunpeaks Ventures, Inc. and changed its name to Pharmagen, Inc. in January 2013. Pharmagen, Inc. is based in Silver Spring, Maryland.
The current price of PHRX is $0 USD — it has increased by +0% in the past 24 hours. Watch Pharmagen stock price performance more closely on the chart.
What is Pharmagen stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pharmagen stocks are traded under the ticker PHRX.
Is Pharmagen stock price growing?▼
PHRX stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Pharmagen has showed a +0% increase.
What were Pharmagen earnings last quarter?▼
PHRX earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Pharmagen have?▼
As of April 06, 2026, the company has 24 employees.